1. Introduction {#sec1}
===============

*Dirofilaria immitis* is a mosquito-borne-filarial nematode that causes dirofilariasis or heartworm disease in dogs and cats, and occasionally infects humans. For approximately the last 25 years, prevention of heartworm infection has been solely dependent on a single drug class, the macrocyclic lactones (MLs). Two sub-groups of MLs, namely the avermectins - ivermectin (IVM) and selamectin, and the milbemycins -- moxidectin and milbemycin oxime - are used as heartworm preventatives ([@bib69]). However, there have been reports of loss of efficacy (LOE) of these MLs against heartworm in the USA, especially in those areas where heartworm challenge is high ([@bib41]). Recent studies have confirmed, using *in vivo* efficacy studies and genetic analysis, actual ML resistance in *D. immitis* ([@bib12], [@bib11], [@bib95]). There also exists some evidence of ML resistance in the human parasite, *Onchocerca volvulus* ([@bib85], [@bib84], [@bib79], [@bib80], [@bib90]), a filarial nematode which is closely related to *D. immitis*. Considering the range of nematode parasites in animals and humans, anthelmintic resistance occurs against virtually all of the major families of broad spectrum anthelmintics, including the MLs, the benzimidazoles, levamisole and monepantel ([@bib62]). In the absence of effective vaccines or means to prevent infection, both treatment and prophylaxis for most helminth parasites relies mainly on the use of these drugs. Since resistance is an increasing, serious concern there is an urgent need to develop new classes of anthelmintic drugs.

Current programs of anthelmintic drug discovery, especially those that operate in industrial settings, focus primarily on the discovery of new drugs for veterinary indications: mainly gastrointestinal nematodes of livestock and companion animals, and canine heartworm ([@bib113], [@bib114], [@bib112], [@bib35]). Furthermore, it is worthy of note that many of the anthelmintics used in human medicine were originally developed for the veterinary sector ([@bib35]). In terms of economic factors, in the USA alone, with over 80 million dogs, and with heartworm drugs costing US \$75--100/dog per year ([@bib38]), there exists an attractive market for heartworm drug development. Any new pharmaceutical for heartworm control may also benefit efforts to control filarial and potentially other parasitic infections in humans ([@bib110]).

The neuromuscular system of *D. immitis* shows great potential as a drug target; nematodes have well-developed neuromuscular systems that control motility, navigation, feeding, mating and responses to environmental cues, which are essential for their survival, development and reproduction ([@bib107], [@bib89], [@bib39]). Interference with any of these activities can paralyse, kill or stop reproduction in the parasite ([@bib39]). Ion channels and associated receptors that underlie neuromuscular systems are targets for a wide variety of naturally occurring toxins and synthetic compounds ([@bib19]). Ion channels are targets for many nematocidal drugs currently in the market ([@bib109]). Furthermore, any new drug that acts on these receptors can be easily screened, in a semi-automated manner, for anthelmintic activity based on its effect on worm motility ([@bib109]). Ion channels of nematodes may be classified by the type of ions that are allowed to pass through them (e.g. cations (Na^+^, K^+^ and Ca^++^) or anions (Cl^−^)), and by the type of gating: voltage gated (sodium, calcium or potassium channels) or ligand gated (in which the ligand may be an amino-acid such as glutamate, ɤ-amino butyric acid (GABA), or a biogenic amine such as serotonin, tyramine or dopamine) ([@bib109], [@bib39]). Among the ligand-gated ion channels (LGICs), the cysteine-loop (cys-loop) superfamily includes cation-permeable acetylcholine receptors as well as anion-selective channels gated by GABA, glutamate, 5-hydroxytryptamine, dopamine or tyramine ([@bib96], [@bib42], [@bib98], [@bib68]). A complete inventory of the homologs of these channel genes, in *D. immitis*, is so far unknown.

Due to current screening activities based on worm motility, there are good chances that ion channels and receptors in *D. immitis* will be targets for new anthelmintics. Genetic variability, in the form of single nucleotide polymorphism (SNPs), insertions or deletions (indels), in ion channel and receptor genes may create structural changes in the protein products. Such changes may alter the physiochemical or structural properties, disrupting folding, affecting stability or function of the protein, or making it totally a null receptor for a drug effect ([@bib66]). Genetic changes within ion channel genes may also modulate their expression levels and such changes, though not examined here in this study, could be a source of variability in channel properties ([@bib77]). Knowledge of possible polymorphism in ion channels and associated receptors in *D. immitis* may be relevant for drug design processes. In addition, such knowledge can be used to make sure that any new drug is active against all of the allelic forms of the target, including allelic variants found in LOE populations. Furthermore, heterogeneity in an ion channel drug target may facilitate resistance development ([@bib92], [@bib14]) and knowledge of that heterogeneity may be informative in anticipating possible resistance development. The objectives of this study were to identify all the putative ion channel genes/subunits in *D. immitis* by comparative genomic approaches and to analyze them for polymorphism.

2. Materials and methods {#sec2}
========================

2.1. Identification of all the ion channel genes of D. immitis {#sec2.1}
--------------------------------------------------------------

The nDi.2.2 genome of *D. immitis* is in draft stage ([@bib37]) and the gene annotation is not complete ([@bib11]). A complete inventory of ion channel genes of *D. immitis* is not available. To identify all the putative ion channel genes/subunits in the genome of *D. immitis,* a complementary approach was followed. Protein-encoding genes from the assembled *D. immitis* contigs were predicted and validated by [@bib38] using three parallel strategies; i) prediction with the *ab initio* gene finders SNAP ([@bib61]) and Augustus ([@bib103]) using the training set of *Brugia malayi*, ii) direct alignment to *B. malayi* proteome and iii) alignment to the RNA-seq assembly ([@bib37], [@bib64]). Thus, all the ion channel genes so far annotated and available in the GFF (Generic Feature Format) file format under Nuclear Annotation Freeze nDi.2.2.2 in the *D. immitis* website (<http://nematodes.org/genomes/dirofilaria_immitis/>) were used. To study the un-annotated homologs of *D. immitis* ion channel genes, nucleotide sequences of all the genes or subunits that belong to the family of cys-loop LGIC, voltage-gated (e.g., potassium, calcium) and other channel types of all nematodes were extracted from available databases such as NCBI (<http://www.ncbi.nlm.nih.gov/>), Wormbase (http://www.wormbase.org/\#01-23-6), Broad Institute (<https://www.broadinstitute.org/>) and NEMBASE4 (<http://www.nematodes.org/nembase4/>). These sequences were then blasted (BLASTN 2.2.25) ([@bib2]) in the nucleotide blast server v2.2 [(]{.ul}<http://nematodes.org/genomes/dirofilaria_immitis/>[)]{.ul} to locate each of the putative ion channel genes in the scaffolds of the *D. immitis* nuclear genome (version nDi.2.2.2) (<http://salmo.bio.ed.ac.uk/cgi-bin/gbrowse/gbrowse/nDi.2.2.2/>).

2.2. Synchronized file generation to assess polymorphism in ion channels {#sec2.2}
------------------------------------------------------------------------

Pooled worm samples and the method followed for synchronized file generation for genetic variability analysis were as previously described ([@bib11]) except that the reference genome used was different in this study. Briefly, our study samples included a total of 122 worms from 17 ML susceptible dogs from the USA (Missouri isolate), Gran Canary (Spain), Grenada (West Indies) and Italy (Po Basin, Northern Italy). All worms from each country population were pooled, resulting in 4 pools for susceptible worms. Other phenotypic populations included ∼8000 microfilariae (mfs) from each of 4 ML-LOE dogs, originally from four different locations in the USA (Mechanicsville, VA; New Orleans, LA; Haywood County, TN; Monroe, LA). Loss of efficacy to MLs in such dogs was assessed, as described in [@bib11]. Mfs from each individual LOE dog were analyzed as a pool, resulting in 4 pools for LOE samples. All 8 pooled samples were subjected to whole genome sequencing using the HiSeq2000 platform from Illumina^®^ by Illumina Next Generation Sequencing (The McGill University and Genome Quebec Innovation Centre) and Bam files, corresponding to the alignment of the reads from each population against the reference genome, were generated. *D. immitis* nuclear genome v2.2 (<http://nematodes.org/genomes/dirofilaria_immitis/>) was used as the reference genome for the alignment. The program, PoPoolation2, which allows comparison of nucleotide frequencies of two or more populations and identifies any significant differences in nucleotides at a position among populations ([@bib58]), was used to generate a synchronized file. After filtering for base quality, the synchronized file contained nucleotide (read) frequencies for every position for every population along the length of the reference genome. Based on the population read frequencies obtained for every gene/subunit in the synchronized file, a locus was considered to be polymorphic and different if a change in nucleotide frequency at that locus was \>15% different between populations, a threshold limit set on the basis of the number of reads and the base pairs covered for SNP genotyping.

2.3. Nomenclature, classification of identified ion channels {#sec2.3}
------------------------------------------------------------

Naming of the identified ion channel genes/subunits was based on their respective orthologs in *Caenorhabditis elegans* during BLAST searches. These names may change in the future based on phylogenetic analysis. The gene description for the ion channels was the same as given during annotation; available as nuclear annotation freeze nDi.2.2.2 in the website <http://nematodes.org/genomes/dirofilaria_immitis/>. Classification of each ion channel of *D. immitis* into sub-groups/sub-classes was done as previously described for the neuronal genome of *C. elegans* ([@bib42]).

2.4. Assessment of position, type and impact of identified polymorphism {#sec2.4}
-----------------------------------------------------------------------

A GFF file containing the nuclear annotations of the nDi.2.2.2 version of the *D. immitis* genome [(]{.ul}<http://nematodes.org/genomes/dirofilaria_immitis/>[)]{.ul} was used to identify whether a SNP was located in an intron or an exon region of a transcript. Protein sequence predicted for every gene annotation, available as file "Protein predictions from nDi.2.2.2" in the same website, was used to locate the position of amino acid changes within a protein. For the un-annotated genes, all the exon regions of a gene were predicted, combined and translated to confirm the full length of a gene. The type of single nucleotide polymorphism, synonymous (nSNP) or non-synonymous (nsSNP), was determined using Sequencher software 4.10.1 (Gene Codes Corporation, 2010). PSIPRED (<http://bioinf.cs.ucl.ac.uk/psipred/>), a general purpose secondary structure predictor (SSP) and a highly accurate SSP tool for ionic channels ([@bib60]) was used to predict the effect of non-synonymous mutations in the secondary structure of a gene/subunit.

2.5. Focus on potential drug targets and their polymorphism {#sec2.5}
-----------------------------------------------------------

To highlight any potential *D. immitis* drug target (and its polymorphic forms), a similar filtering methodology was used as was followed for *B. malayi* ([@bib65]) and *D. immitis* ([@bib38]). One of the filters used was that their respective orthologous gene should have had deleterious effects following gene knockout studies in *C. elegans*. Such deleterious effects could be embryonic lethal/larval arrest, shortened life span, locomotion variant, organism development variant, sluggish/fainter, slow growth, egg size defective, or pharyngeal pumping variant, as shown in the Wormbase website (<http://legacy.wormbase.org/>). A second type of filter used was the absence of a BLASTP (<http://blast.ncbi.nlm.nih.gov/Blast.cgi?PROGRAM=blastp&PAGE_TYPE=BlastSearch&LINK_LOC=blasthome>) hit with an E-value below 10^−5^, in the predicted proteomes of *Homo sapiens* and *Canis lupus familiaris* ([@bib38], [@bib64]).

3. Results {#sec3}
==========

3.1. Number of ion channel genes/subunits studied for SNP genotyping {#sec3.1}
--------------------------------------------------------------------

A total of 1249 nucleotide sequences for all the known ion channel genes/subunits of both free living and parasitic nematodes were extracted from NCBI and nematode databases (Supplementary file 1, [Table S1](#appsec1){ref-type="sec"}). Complete information of these extracted nucleotide sequences is available in Supplementary file 2, [Table S2](#appsec1){ref-type="sec"} (worksheet "Details of extracted sequences"). We identified 224 genes/subunits in total (Supplementary file 2, [Table S2](#appsec1){ref-type="sec"}, worksheet "Ion channel genes in *D. immitis*") that covered 965,735 base pairs (bps) ([Table 1](#tbl1){ref-type="table"}); about 1.1% of the ∼84.2 Mb sized nuclear assembly of *D. immitis* ([@bib37]). All of the 224 genes/subunits included for SNP genotyping were either identified from BLAST hits in the *D. immitis* nucleotide blast server (nDi.2.2) with extracted nucleotide sequences of ion channels of related nematodes or those ion channels were already annotated in the *D. immitis* genome (<http://salmo.bio.ed.ac.uk/cgi-bin/gbrowse/gbrowse/nDi.2.2.2/>).

3.2. Polymorphic pattern in ion channel genes of D. immitis {#sec3.2}
-----------------------------------------------------------

Among the eight pooled samples studied for polymorphism within the 224 genes/subunits of ion channels in *D. immitis*, we identified 1762 SNPs (Supplementary file 3, [Table S3](#appsec1){ref-type="sec"}) with a nucleotide diversity rate of 0.18% ([Table 1](#tbl1){ref-type="table"}). This number of SNPs was obtained after using 15% as the threshold level for SNP calling at a position. If the alternative nucleotide frequency at a locus was set at ≥20% in order for a position to be considered polymorphic, then 1504 of the 1762 loci were retained. About 85.5% of the SNPs identified were in intron regions with an intronic SNP rate of 1/463 bp, whereas the remaining SNPs were in exons with an exonic SNP rate of 1/1051 bp. One hundred and twenty nine of 254 SNPs in exons caused non-synonymous polymorphism, 14 of which changed secondary structure of the protein as predicted by PSIPRED. The nsSNPs identified in this analysis are in most cases described in detail. The polymorphic rates, calculated for each population as a percentage of the total SNPs identified, are given in [Table 2](#tbl2){ref-type="table"}. A similar polymorphic rate (around 70%) was seen in pooled populations from the USA, Grand Canary and Grenada. However, a lower polymorphic rate (43%) was identified in the pooled samples from Italy.

3.3. SNPs in Cys-loop LGIC {#sec3.3}
--------------------------

The genome of *D. immitis* was found to contain 81 genes/subunits that could encode 42 unique genes (15 nAChR, 1 ionotropic glutamate receptor (iGluR), 6 ACh-gated, 6 GABA-gated, 5 glutamate-gated, 2 biogenic amine-gated and 7 genes in a diverse group). From all of the genes encoding Cys-loop LGICs studied for SNP analysis, 410 SNP loci were identified. Of the 64 SNPs in exon regions, 39 were nsSNP. In this superfamily of cys-loop LGICs, an overall polymorphic rate of 0.17% was noticed with 0.14 and 0.33% in cation-selective nAChR and ionotropic glutamate receptors, respectively. Anion-selective channels such as acetylcholine-gated, GABA-gated, glutamate gated and the biogenic amine-gated subgroup were found to have polymorphic rates of 0.08, 0.32, 0.18 and 0.15%, respectively ([Table 3](#tbl3){ref-type="table"}).

SNPs in the exon regions of nAChR-types of the cys-loop LGIC superfamily, such as *acr-8, acr-11* and *acr-16* were recorded ([Table 4](#tbl4){ref-type="table"}). The gene *acr-8* identified in the scaffold nDi.2.2.scaf00069 had a deletion mutation at the 65th amino acid position and the percentage of deletions was 33% in susceptible populations compared to 64% in LOE populations. The other subunit of *acr-8* in the same scaffold was identified to have three SNPs with R364G in particular causing a change in predicted secondary structure of the protein ([Fig. 1](#fig1){ref-type="fig"}). In the homolog of coelomocyte-specific gene *cup-4*, identified in the scaffold nDi.2.2.scaf01506, a SNP was identified at position 141 between aliphatic isoleucine and acidic amide asparagine. In *C. elegans*, the *cup-4* gene was shown to be required for efficient endocytosis of fluids by coelomocytes ([@bib88]) and the loss-of-function RNAi studies showed increased sensitivity to oxidative stress and reduced lifespan ([@bib87]). Among the acetylcholine gated chloride channel genes studied, both *acc-3* and *lgc-47* were identified with the SNPs Y311D and Y256D, respectively. *D. immitis* has five GluCl encoding genes namely *glc-2, glc-3, glc-4, avr-14* and *avr-15;* three of these genes had SNPs in exon regions. The homolog of the *avr-14* gene in *D. immitis* had two SNPs, C382F and C385F. The presence of these two adjacently positioned SNPs was predicted to cause a change in secondary structure in the flanking region ([Fig. 1](#fig1){ref-type="fig"}). The *glc-2* homolog was found with two SNPs, Q90E and V381A, with the latter causing a change in the predicted secondary structure. Another GluCl gene homolog of *glc-4* had a SNP at T375K. The glutamate-gated cation channel (ionotropic glutamate receptor) gene *glr-1* homolog in *D. immitis*, was identified with two SNPs, N287S and P809T. The former was specific to LOE, and the latter to susceptible populations. GABA-gated channel gene *gab-1* had a SNP, I20T identified only in the susceptible populations, whereas the other gene, *unc-49* with N57D polymorphism was in both susceptible and LOE populations. SNP loci were also identified in the homologs of the dopamine gated channel gene *lgc-53,* tyramine gated channel gene *lgc-55* and also in uncharacterized members of the cys-loop LGIC superfamily, such as *lgc-*39, *lgc-*41, *lgc-*44 and *lgc-45.*

3.4. Potassium channels {#sec3.4}
-----------------------

Seventy three of the gene annotations in the nDi.2.2 genome encode 43 potassium channel genes (plus 1 auxiliary subunit), with representatives for each of the three major classes: 2-pass (3 genes), 4-pass (23 genes) and 6-pass (14 genes) transmembrane proteins. With 284 SNPs in these voltage gated channels, a polymorphism rate of 0.09% was observed; lowest among the genes studied ([Table 5](#tbl5){ref-type="table"}). A SNP at amino acid position 99 of the inward rectifier potassium channel gene *irk-3,* caused an amino acid variant between arginine (basic amino acid) if the corresponding codon was CGA and glycine (aliphatic amino acid) if the corresponding codon was GGA. Homologs of potassium channels with 4-transmembrane topology, namely *twk-48* and *twk-8*, were polymorphic with SNPs I171T and M468V, respectively. The latter caused a change in predicted secondary structure. The SNP in the gene *twk-8* was in the susceptible populations only, but was well conserved with methionine in the LOE populations. A subunit of the *twk-47* gene homolog in *D. immitis* was identified with a SNP V9A, with predominantly valine at this position in the susceptible populations and alanine in the LOE populations. Two subunits of the gene *twk-18*, which existed as gene clusters in the same scaffold of nDi.2.2.scaf01557, were found to be polymorphic, with one of the subunits having 4 SNPs, including a SNP that leads to a stop codon. The other subunit had 2 SNPs (M1V and H5D) towards the 5′ end of the gene. Homologs of the six-pass transmembrane channel genes in *D. immitis* such as *exp-2, kvs-4* (K~v~2 subfamily), and *shw-1, shw-3* (K~v~3 subfamily) were found to have a single SNP in each (see [Table 6](#tbl6){ref-type="table"}). In the *kvs-4* homolog gene, a locus with the SNP T208I was more common in the LOE populations than in the susceptible populations. A couple of SNPs, identified in the potassium channel gene containing a tetramerisation domain (homolog of uncharacterized *C. elegans* gene F59F3.6), with SNP I194M in particular, being predicted to cause a change in the secondary structure of the protein ([Fig. 1](#fig1){ref-type="fig"}). A secondary structure change caused by a SNP (H346R) in a calcium activated potassium channel gene, *kcnl-2,* was found to be present only in the LOE populations. An auxiliary subunit and a multipass transmembrane protein, *unc-93* had a SNP R131Q that was only observed in the susceptible populations.

3.5. Calcium channels {#sec3.5}
---------------------

The nDi.2.2 *D. immitis* genome contained four α~1~ subunits, one α~2~∂ subunit, one β subunit and two auxiliary proteins. Out of 26 gene annotations that could encode 9 unique genes, 321 SNPs were observed with a polymorphic rate of 0.18%. Investigation of these calcium channels for SNP genotype revealed the presence of SNPs in the homologs of phylogenetically defined L-type ('long-lasting') gene *egl-19*, Non -- L (P/Q) -type gene *unc-2*, T-type ('transient') gene *cca-1* and also in *nca-2*, an α~1~U branch of invertebrate cation channel ([@bib42]) ([Table 7](#tbl7){ref-type="table"}). In gene *nca-2*, a SNP resulting in either glutamate or lysine at position 1619, could be of importance since its RNAi phenotype is embryonic lethal in *C. elegans*. A SNP predicted to cause a secondary structure change ([Fig. 1](#fig1){ref-type="fig"}) was found to be present at amino acid position 147 of the α~2~∂ subunit gene *unc-36*. The SNP V147G was present mainly in the susceptible populations. Multiple SNPs were identified in the Ryanodine receptor (RyR) class of intracellular calcium channels. Among the auxiliary proteins of calcium channels, two SNPs (A141T, F144L) in *unc-79*, and a T1836M SNP in *unc-80* were identified. Orthologs of these genes in *C. elegans* had RNAi detrimental effects ([@bib52]).

3.6. Chloride channels {#sec3.6}
----------------------

Nine membrane localized chloride channels were identified; five from the chloride channel (CLC) family, two from the chloride intracellular channel (CLIC) family and two from the bestrophin-related channel types. Two hundred and sixty five SNPs were identified among these 9 chloride channel genes with a polymorphic rate of 0.48%; highest among the channel types studied. In the CLC-type *clh-1* gene homolog, two closely positioned SNPs A300G and V302F were identified. In the other CLC-type gene *clh-3,* we found two SNPs at positions 915 (Q915K) and 1095 (S1095N). A single SNP N325H was identified in the *clh-5* gene homolog. The *clh-6* gene was multi-polymorphic as we identified 9 missense types of polymorphism in this gene. Bestrophin-related calcium-activated chloride channel genes, namely *best-13* and *best-24* were found to be polymorphic (see [Table 8](#tbl8){ref-type="table"}). One of the subunits of the *best-24* gene had a premature stop codon causing polymorphism, whereas the SNP L75M, found in the other subunit, caused a change in predicted secondary structure.

3.7. Other type of channels {#sec3.7}
---------------------------

From the DEG/ENaC (DEGenerin/Epithelial Sodium Channels) protein family of *D. immitis*, we identified 8 annotations that could encode 7 genes. The calculated polymorphic rate within this group of sodium channels was 0.2%. One SNP in each of the amiloride-sensitive sodium channel genes, namely *unc-105, acd-1, acd-5* and *del-10*, was identified (see Supplementary file 4, [Table S4](#appsec1){ref-type="sec"}). Double SNPs, F33L and D148N were seen in *del-10.* The TRP (Transient Receptor Potential) superfamily of cation channels were 7 in number in the *D. immitis* genome. These canonical TRP channels carried 319 SNPs in both introns and exons, with a polymorphism rate of 0.38%. Both the first and second SNPs were found in codon 214 of the gene *spe-41*, changing alanine to valine or serine. In the *trp-4* gene, 3 SNPs, T83P, A538T and S894A, were identified; the first predicted to cause a secondary structure change from helix to coil. Another TRP channel gene, *ced-11*, was found to be highly polymorphic with 15 variable loci identified in the exon regions alone. So far, the genome of *D. immitis* was found to have three cation-selective cyclic nucleotide gated (CNG) ion channel genes, namely *tax-2*, *tax-4* and *che-6*, that respectively encode β, α, and α/β subunits ([@bib102]). A single polymorphic site T106I was found in the β-type subunit gene, *tax-2*, whereas the other subunit gene, *che-6*, was also highly polymorphic (see Supplementary file 3, [Table S3](#appsec1){ref-type="sec"}). The gene *ncs-4* ("neuronal calcium sensor") belonging to the calcium binding protein family had a SNP at amino acid position E169K. Also, a single SNP, V124I was found in the cation channel, and 2 SNPs, F30L and S66G, were observed in an unnamed voltage-dependent anion channel. The presence of these amino acid changes were predicted to cause secondary structure changes in the protein.

4. Discussion {#sec4}
=============

Parasitic nematode associated diseases cause serious health issues in millions of humans ([@bib47], [@bib46], [@bib16], [@bib71]) and animals (both domestic and livestock) each year ([@bib9], [@bib76], [@bib22]). MLs have been the drugs of choice to treat and/or to prevent many parasitic nematode infections, including heartworm in dogs ([@bib33], [@bib82], [@bib93]). In recent times, many of the existing anthelmintics, including the MLs, have begun to face problems of emerging resistance. Therefore, improved diagnostics, new drugs and effective vaccines are important goals for efficient control and prevention of parasitic diseases. For the animal health sector, there has been an increased focus on the discovery of new drugs for canine heartworm ([@bib35]). In the context of discovering new anthelmintics, it is of interest that ion channels in the neuromuscular systems of nematodes have been successful drug targets for many of the anthelmintics discovered in the past, and remain targets of choice for discovery of new anthelmintics ([@bib109], [@bib39]).

In this study, we employed comparative genomic approaches, by using ion channel gene sequences from related nematodes, to localize their homologs in the nDi.2.2 genome of *D. immitis*. A total of 224 genes/subunits that are likely to encode 126 unique ion channels and receptors genes were identified. The genome of *D. immitis* has 42 cys-loop LGIC (15 cationic nAChR, 1 cationic iGluR, 19 anionic chloride channels and 7 diverse channel genes). This is similar to the 44 receptor genes (21 nAChR-like genes and 23 chloride channel subunits) reported in the closely related *B. malayi* genome ([@bib101]), but fewer compared to 102 LGIC genes (52 nAChR, and 50 chloride channel genes) in *C. elegans* ([@bib51]). We report that the genome of *D. immitis* may have at least 43 voltage-gated potassium channels; close in number to the 36 in *B. malayi* ([@bib101]) but fewer than the 72 reported in *C. elegans* ([@bib42]) and 80 in mammals ([@bib86]). Six subunits encoding calcium channel genes (also 2 auxiliary subunits) were identified in *D. immitis*, with four encoding α~1~ subunits, one each encoding α2∂, β subunits. In *C. elegans*, 5 genes encode α~1~, 2 β, and 2 α~2~∂ subunits ([@bib42]). Among the chloride channels, 5 were identified from the CLC type, 2 CLICs and 2 genes from the bestrophin-related genes, compared to 6 genes of the CLC and 26 bestrophin-related genes found in *C. elegans* ([@bib100], [@bib42]). We also identified 7 genes that belong to DEG/ENaC/ASIC channels and another 7 belonging to the TRP-type channels. This compares with 30 and 23 genes, respectively, in *C. elegans* ([@bib42]).

We aimed at investigating SNPs in these ion channel genes that cover 1.1% of ∼84.2 Mb nuclear assembly of *D. immitis.* Within these ion channel genes, we report an overall polymorphic rate of 0.18%. For each of the polymorphisms, especially for those in the exonic regions, we studied its likely effects, such as a change in amino acid, and change in predicted secondary structure of the protein as it could be relevant for anthelmintic drug development. Furthermore, this study identified all the allelic forms in these ion channels. This information may be used to help ensure that a prospective drug candidate is active against different genetic forms. As we also used genomic data from pooled LOE populations for genotyping, the populations' specific genetic variants were also identified. This information may be helpful to check the effectiveness of a new drug, even against ML LOE populations. Moreover, the polymorphic knowledge of ion channel targets may help to anticipate resistance development, as the more heterogeneous a drug target is, the greater the potential for resistance to develop ([@bib92]).

We analyzed polymorphic rates per geographical location and found rates of 75.2, 70.9, 70.0 and 43.0% in pooled populations from the USA, Grand Canary, Grenada and Italy respectively. A low polymorphic rate in the sample of worms from Italy may be explained by the fact that the worms were from a single dog, in contrast to worms coming from other countries in which several dogs donated worms. Thus, barring the Italian samples, we saw a trend of low genetic variability among ion channel and receptor genes between populations from the USA, Grand Canary and Grenada. This hypo-variability, though not anticipated, is in agreement with the population genetic results studied at the microsatellite level ([@bib7]) and also at the whole genome level ([@bib38]). However, [@bib38] used only two different *D. immitis* isolates, one from Italy and the other from the USA to draw this conclusion. Our findings could support the hypothesis that heartworm disease is a New World disease ([@bib15]). However, canine heartworm was reported for the first time in Italy in 1626 ([@bib8]) but is known to have been present in the USA from 1847 ([@bib83]). On the other hand, the result of our study is in contrast to reports suggesting that *D. immitis* has considerable genetic variability ([@bib34], [@bib14]). These earlier studies were based on only 5 gene sequences in individual adult worms from the USA (field and laboratory samples) and Japan (field samples). It must also be kept in mind that in the current study we did not analyze polymorphism when it occurred in less than 15% of the reads of a sequence. Thus, additional polymorphism may occur at low levels. Other parasitic nematodes have marked genetic variability such as *Ascaris lumbricoides* ([@bib27]), *Haemonchus contortus* ([@bib21]), *Telardorsagia circumcincta* and *Mazamostrongylus odocoilei* ([@bib40]). However, these studies were conducted on whole genomes and some genes may be more conserved than others. Therefore, it is not appropriate to compare genetic variability in a subset of genes in one organism with different genes in other organisms. *D. immitis* appears to be a nematode with a relatively low level of heterogeneity in ion channel genes. Genome wide studies need to be done on worms from different locations to make definitive conclusions on the overall degree of heterogeneity in *D. immitis*.

Genetic changes either in the form of insertions/deletions (indels) or mutations in the intron region of a gene can influence splicing ([@bib63]), structure and function of a protein, and the possibility of resistance selection ([@bib5]). For example, an indel of 63 bp present in intron 2 of the *H. contortus* gene, *Hco-acr-8* was found to be responsible for the truncated isoform of the protein *Hco-*ACR-8b and this genetic change correlated significantly with levamisole resistance ([@bib5]). Also, an intronic SNP out of the diplotypic GG-GG genotype in *Dim-pgp-11* of *D. immitis* ([@bib10]) occurs at the intron region of the 3′ end of the gene. This diplotypic genotype strongly correlated with *in vitro* ([@bib13]), and *in vivo* responses of mf to IVM ([@bib12]). Accordingly, a few of the 1508 SNPs (82% of total polymorphism) identified within intron regions of the 244 genes/subunits of ion channel genes could have implications for gene expression, response to drugs ([@bib106]), resistance development ([@bib5]), or other effects, which would need to be confirmed in future investigations. Also, 125 SNPs found within exon regions caused synonymous type variation. There is therefore a possibility that a few of these SNPs might have implications either for aberrant mRNA splicing ([@bib20]) or affect mRNA stability that could impact protein expression ([@bib78]) or change protein conformation. Such effects could lead to changes in protein function ([@bib57]).

This study also identified 129 SNPs that are in exon regions and caused amino acid changes. A few of the nsSNPs may be critical as they were found in ion channels identified as potential drug targets based on two criteria: the detrimental effect of knockout of its homolog gene in *C. elegans* and absence of a homolog in humans and dogs. The significance of the nsSNPs was analyzed on the basis of changes in predicted secondary structure in association with a change in amino acid.

Glutamate gated chloride channels (GluCls) are proven targets for macrocyclic lactones. GluCls are invertebrate specific and play a key role in locomotion, feeding and sensory input ([@bib39]), and therefore are attractive drug targets. AVR-14, in particular, is an interesting target as it is well conserved in all nematodes studied so far ([@bib67], [@bib50], [@bib115], [@bib81], [@bib105]). GluCls are expressed on motor neurons ([@bib29], [@bib91], [@bib36]) that mediate locomotion, feeding, reproduction and secretion/excretion from the excretory pore. Considering this, the AVR-14 of *D. immitis* (GenBank: [CAE46429.1](ncbi-p:CAE46429.1){#intref0075}) could act as a drug target; two adjacent SNPs, C382F and C385F, identified in this study could be critically important from a drug design perspective. The homolog of this gene in *C. elegans* has a locomotion coordination variant phenotype following RNAi ([@bib26]).

Nicotinic acetylcholine receptors (nAChRs), the most common targets of current anthelmintics, are a diverse group of receptors with interesting pharmacology ([@bib109], [@bib39]). nAChRs are pentameric structures with a wide variety of potential subunits that provide them with considerable receptor diversity, and distinct structural properties and pharmacological sensitivities ([@bib39]). Although the possibility of rapid development of resistance, and cross-resistance between drugs that target these receptors, has been anticipated as nematodes may alter receptor sensitivity to different anthelmintics by varying the stoichiometry of subunits ([@bib108], [@bib18]), it was shown that this possibility may not be true at least in the case of neuronal nAChRs targeted by monepantel ([@bib54]). nAChRs get expressed at the neuromuscular junction, nerve ring and in the pharynx of *C. elegans* ([@bib51]). Therefore, nematode nAChRs, including those in *D. immitis,* may be good targets for new anthelmintics. Among the polymorphisms identified in the putative nAChRs genes of *D. immitis,* SNPs identified in *acr-8, acr-11* and *acr-16* genes need special mention. Three SNPs (L256F, Y264F, R364G), including a secondary structure change caused by R364G in *acr-8*, and a deletion-causing SNP in the other subunit of the *acr-8* gene, were identified. The *acr-11* gene has a detrimental RNAi phenotype in *C. elegans* and its homolog in *D. immitis* has been identified with a SNP Q46P. The other nAChR gene, *acr-16* was found to have three close SNP loci, at P40S, L43F and S53L.

Inhibitory GABA-gated chloride channels present at the neuromuscular junction of nematodes ([@bib44], [@bib97]) mediate the relaxation phase of sinusoidal muscle movement ([@bib1]) and so any drug-induced activation, for example by the anthelmintic piperazine, a GABA agonist, can cause flaccid paralysis of worms ([@bib73]). MLs also appear to bind to GABA-gated chloride channels of nematodes ([@bib32], [@bib17]). Therefore, these channels can be fruitful drug targets. GABA receptors of *D. immitis*, namely the homologs of *gab-1* and *unc-49* with identified SNPs I20T and N57D, respectively, may be of interest for drug intervention. The gene *unc-49* (and its associated SNP) is worthy of mention as its homolog gene in *C. elegans* has proven expression in somatic muscle at the neuromuscular junction and therefore plays an important role in locomotion ([@bib4]). Nematodes possess serotonin, dopamine, tyramine and ACh-gated anion channels not found in mammals ([@bib109], [@bib6], [@bib72]). Therefore, the SNPs in the tyramine-gated receptor coded by *lgc-55*, and the dopamine-gated receptor coded by *lgc-53* could be of interest during drug development. iGluR gene *glr-1* of *D. immitis*, with its SNPs N287S, P809T, could be an interesting drug target, as such receptors have been found to play vital roles in the nematode nervous system ([@bib3], [@bib55]).

Voltage gated ion channels function in response to changes in membrane potential and gate calcium (Ca~v~ channels) or potassium (K~v~ channels) in nematodes. This type of voltage-gated ion channel represents a class of outstanding but underexploited drug targets ([@bib19], [@bib28]). To date, only two members of the voltage-gated ion channels, namely Ca^2+^- activated potassium channel gene *slo-1* and a schistosome calcium channel gene have been implicated in the action of anthelmintics: emodepside and praziquantel, respectively ([@bib109]). The genome of *D. immitis* encodes 43 potassium, 6 calcium channel genes but no voltage-gated sodium channels. The potassium channel genes, *twk-18* and *twk-47* were found to be nematode specific targets and our study has identified SNPs in each of the genes. Further study may be warranted to understand the implications of the identified SNPs, M1V, H5D (*twk-18*) and V9A (*twk-47*), on the functionality of the respective proteins. A SNP (H346R), which may be of importance, was found in the small conductance Ca^2+^ -activated K^+^ (SK) channel gene *kcnl-2,* wherein the homolog of this gene is required for regulating the rate of egg-laying in *C. elegans* ([@bib23]). The α~1~ subunit encoding calcium channel genes, such as *nca-2* and *egl-19* with SNPs (E1619K and T1447P, respectively) could be good targets for future anthelmintic discovery, considering the fact that their respective homolog genes in *C. elegans* were found to have RNAi detrimental phenotypes ([@bib53], [@bib48]). An intracellular Ryanodine receptor (RyR) calcium channel encoded by the *unc-68* gene is well conserved in nematodes ([@bib75]) and is localized in muscles ([@bib42]) and in neurons ([@bib70]) of *C. elegans*. Also, the phthalic acid diamide and anthranilic diamide classes of insecticides act on the RyR receptor ([@bib99]). Considering this, the RyR receptor homolog of *D. immitis* could be an attractive drug target. However, this gene was found to be highly polymorphic (both intronic and exonic SNPs) and so the chances of resistance being selected against drugs that target this gene product could be high. In *D. immitis*, CLC type chloride channel genes, namely *clh-1*, *-3*, *-5* and *-6*, which potentially control the membrane potential of cells, were found to have polymorphic site(s). However, the significance of these SNPs has yet to be studied. There were also two bestrophin-related chloride channel genes identified in *D. immitis*; the *best-24* gene homolog is of interest since the gene is expressed in neurons in *C. elegans* ([@bib42]). For the same reason, SNPs identified in the gene, mainly the one causing a stop codon and the other causing a change in predicted secondary structure, may have interesting effects.

Nematodes possess several other families of ion channels in the nervous system that could also be exploited as drug targets. For examples, the DEG/ENaC (Degenerin/Epithelial Sodium Channel) family of sodium channels have been implicated in mechanotransduction and mechanosensitive behaviour in *C. elegans* ([@bib104]). Activating this type of sodium channel in the worms was found to cause inappropriate cell death ([@bib30]) due to their constitutive activation ([@bib45]), and so any agonist drug could be a potential anthelmintic ([@bib109]). From this study, SNPs were also found in DEG/ENaC channel genes such as *unc-105, acd-1, acd-5* and the worm-specific gene *del-10*. TRP channels, a superfamily of cationic channels, well represented in both nematodes and schistosomes ([@bib111]), mediate transduction of sensory stimuli and are important in Ca^2+^ signaling cascades. Any dysregulation of these channels could interfere with signal transduction and disrupt Ca^2+^ homeostasis in worms ([@bib39]). SNPs identified in TRP channel genes such as in *trp-4, ced-11* and *spe-41* may, therefore, have interesting effects.

Finally, the genome of *D. immitis* codes for three predicted CNG channels compared to six in *C. elegans* ([@bib56]). A SNP, T106I, was identified in the gene *tax-2,* which could be a potential drug target since its homolog gene regulates thermosensation, chemosensation and neuronal development in *C. elegans* ([@bib24], [@bib59], [@bib25]).

SNPs present either in only susceptible or LOE populations were also highlighted in this study. For example, SNPs such as I20T in the gene *gab-1*, L691P (*lgc-53*), P809T (*glr-1*), I717V (*mgl-2*), A381T (*acd-5*), V147G (*unc-36*), L75M (*best-24)*, Q2H (*unc-*79), to name a few, were specific to susceptible populations. SNPs such as N287S in gene *glr-1*, S53L in *acr-16*, T208I in *kvs-4*, S1095N in *clh-3*, A538T in *trp-4*, H346R in *kcnl-2* and I36M in *che-6* were identified only in the LOE populations. The purpose of highlighting possible phenotypic consequences of SNP variability in populations is to provide a basis to ensure that any new drug is active against all of the allelic variants of the drug target.

5. Conclusion {#sec5}
=============

Our study describes the extensive profile of ion channel and receptor genes in *D. immitis.* This study is the first of its kind to determine genetic polymorphism in ion channels in this parasite, to generate information on possible effects on protein structure and function, and to consider these findings in the context of RNAi phenotypes for homologs of the genes in *C. elegans.* Such information may be useful during drug design and to anticipate polymorphisms which could impact resistance development. Among the total of 1762 SNPs identified, some may affect gene expression, structure and function of the proteins, and resistance selection processes. A merit of this study lies in the large number of samples used for SNP genotyping. Whole genome sequencing data were generated, from 122 ML susceptible adult worms, isolated from 17 dogs from 4 countries, for SNP analysis. In the case of LOE samples, ∼32,000 mf, isolated from 4 ML-LOE dogs from different US states were used ([@bib11]). It is possible that some additional SNPs were not detected in this analysis due to lack of coverage of some sequences in the genome or to the population size and diversity that was analyzed. Moreover, the SNPs that were specific to the LOE populations were called based on a relatively low number of reads, compared to the read frequencies among the susceptible populations, and therefore information specific to the LOE samples should be considered preliminary. Further studies need to be done to confirm the SNPs in field samples and to understand the possible implications of such SNPs in terms of protein structure, function and also any possible interaction of ion channels with potential antiparasitic drugs.
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PSIPRED predicted secondary structure changes in ion channels due to polymorphism. Secondary structure changes predicted for each ion channel are represented by cartoons: ![](fx2.gif) for helix (H), ![](fx3.gif) for strand (E) and ![](fx4.gif) for coil (C). Confidence value for prediction at each position is given as a series of blue bar graphs - ![](fx5.gif). Any change in amino acid due to polymorphism is highlighted in yellow.
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###### 

A summary of ion channel gene/subunit sequences investigated for the *Dirofilaria immitis* SNP analysis.

  Parameter                                      Results
  ---------------------------------------------- ---------
  Number of ion channel genes/subunits studied   224
  Total bases (bp) covered                       965,735
  Intronic bases                                 698,720
  Exonic bases                                   267,015
  Number of SNPs in introns                      1508
  Number of SNPs in exons                        254
  Number of missense causing SNPs in exons       129

###### 

Genetic variability within ion channels and receptors genes of *Dirofilaria immitis* in populations from different locations.

  Geographical locations   No. of SNPs found   Polymorphic rate (%)[a](#tbl2fna){ref-type="table-fn"}
  ------------------------ ------------------- --------------------------------------------------------
  USA                      1203                75.2
  Grand Canary (Spain)     1135                70.9
  Grenada                  1120                70.0
  Italy                    688                 43.0

Number of SNPs identified (as percentage) in each country based on total SNPs identified.

###### 

Summary of SNPs and SNP rate calculated for each sub-family of cys-loop ligand-gated ion channel genes.

  Ion selectivity   Sub-groups   No. of subunits studied   Base pairs covered   No. of SNPs identified   Polymorphic rate (%)         
  ----------------- ------------ ------------------------- -------------------- ------------------------ ---------------------- ----- ------
  Cation            nAChR-type   34 (15)                   88,768               107                      19                     126   0.14
  Cation            iGluR        2 (1)                     18,180               53                       7                      60    0.33
  Anion             ACC          6 (6)                     37,509               26                       3                      29    0.08
  Anion             Aminergic    3 (2)                     33,752               40                       9                      49    0.15
  Anion             GABA-gated   14 (6)                    21,198               59                       8                      67    0.32
  Anion             GluCl        8 (5)                     18,564               26                       8                      34    0.18
  Unknown           diverse      14 (7)                    28,484               35                       10                     45    0.16

No. of unique genes are indicated in brackets.

###### 

SNP analysis of cys-loop LGIC genes/subunits of *Dirofilaria immitis*.

  Putative gene name/Description                                                                 Coverage in nDi.2.2 scaffold         SNP position in the scaffold              Nucleotide change   Amino acid polymorphism
  ---------------------------------------------------------------------------------------------- ------------------------------------ ----------------------------------------- ------------------- -----------------------------------------
  (*lgc-27*) ligand-gated ion channel family member                                              nDi.2.2.scaf00004 (380863..387209)   384,333                                   **T**TG↔**G**TG     L137V
  384,340                                                                                        G**T**A↔G**G**A                      V139G                                                         
  (*lgc-*30) neurotransmitter-gated ion-channel ligand binding domain containing protein         nDi.2.2.scaf00014 (297209..303637)   299,340                                   A**C**T↔A**A**T     T257N
  (*acr-8*)[b](#tbl4fnb){ref-type="table-fn"} nicotinic acetylcholine receptor alpha subunit 8   nDi.2.2.scaf00069 (86715..87299)     87,289                                    C**T**T↔C**-**T     L65Deletion
  (*acr-8*) nicotinic acetylcholine receptor alpha subunit 8                                     nDi.2.2.scaf00069 (89908..93744)     92,048                                    T**A**T↔T**T**T     Y264F
  93,364                                                                                         **C**GA↔**G**GA                      R364G[c](#tbl4fnc){ref-type="table-fn"}                       
  92,025                                                                                         TT**A**↔TT**T**                      L256F                                                         
  (*acr-11*)[a](#tbl4fna){ref-type="table-fn"} cre-acr-11 protein                                nDi.2.2.scaf00565 (17269..21582)     19,839                                    C**A**A↔C**C**A     Q46P
  (*acr-16*)[a](#tbl4fna){ref-type="table-fn"} acetylcholine receptor subunit alpha-type         nDi.2.2.scaf07899 (1..688)           305                                       T**C**A↔T**T**A     S53L
  337                                                                                            TT**G**↔TT**T**                      L43F                                                          
  345                                                                                            **C**CG↔**T**CG                      P40S                                                          
  (*unc-63*) nicotinic acetylcholine receptor alpha subunit                                      nDi.2.2.scaf00751 (16790..21721)     16,834                                    **C**TT↔**T**TT     L353F
  (*cup-4*)[a](#tbl4fna){ref-type="table-fn"} acetylcholine receptor-like protein                nDi.2.2.scaf01506 (618..6786)        1869                                      A**T**T↔A**A**T     I141N
  (*acc-3*) cre-acc-3 protein                                                                    nDi.2.2.scaf00812 (363..7136)        2540                                      **T**AT↔**G**AT     Y311D
  (*lgc-*47) neurotransmitter-gated ion-channel ligand binding domain containing protein         nDi.2.2.scaf00030 (142465..147144)   144,803                                   **T**AC↔**G**AC     Y256D
  (*glc-4*) glutamate-gated chloride channel subunit beta                                        nDi.2.2.scaf00002 (266371..271808)   267,383                                   A**C**G↔A**A**G     T375K
  (glc-2)[a](#tbl4fna){ref-type="table-fn"} Glutamate-gated chloride channel                     nDi.2.2.scaf00035 (124763..129718)   125,276                                   CAA↔GAA             Q90E
  129,561                                                                                        GTG↔GCG                              V381A[c](#tbl4fnc){ref-type="table-fn"}                       
  (*avr-14*)[a](#tbl4fna){ref-type="table-fn"} glutamate-gated chloride channel                  nDi.2.2.scaf00410 (1..5378)          5254                                      T**G**T↔T**T**T     C382F[c](#tbl4fnc){ref-type="table-fn"}
  5263                                                                                           T**G**T↔T**T**T                      C385F[c](#tbl4fnc){ref-type="table-fn"}                       
  (glr-1) Ionotropic glutamate receptor                                                          nDi.2.2.scaf00632 (11556..19637)     15,358                                    A**A**T↔A**G**T     N287S
  19,548                                                                                         **C**CA↔**A**CA                      P809T                                                         
  (*gab-1*) gamma-aminobutyric acid receptor subunit beta-like                                   nDi.2.2.scaf01694 (74..792)          132                                       A**T**C↔A**C**C     I20T
  (*unc-49*) gamma-aminobutyric-acid receptor beta subunit                                       nDi.2.2.scaf01074 (11518..13243)     12,418                                    **A**AC↔**G**AC     N57D
  (*lgc-*53) neurotransmitter-gated ion-channel ligand binding domain containing protein         nDi.2.2.scaf00139 (44015..65641)     49,539                                    C**T**A↔C**C**A     L691P
  (*lgc-*53) neurotransmitter-gated ion-channel ligand binding domain containing protein         nDi.2.2.scaf00238 (35622..42385)     36,421                                    **C**GA↔**G**GA     R375G
  36,422                                                                                         **T**CG↔**G**CG                      F374L                                                         
  36,430                                                                                         A**G**A↔A**A**A                      R362K                                                         
  36,442                                                                                         **C**AA↔**A**AA                      Q368K[c](#tbl4fnc){ref-type="table-fn"}                       
  36,459                                                                                         **T**CC↔ **C**CC                     S372P                                                         
  (*lgc-*39) cre-*lgc-*39 protein                                                                nDi.2.2.scaf02810 (1..1288)          531                                       **C**CA↔**G**CA     P71A
  (*lgc-*41) ligand-gated ion channel family member                                              nDi.2.2.scaf00010 (375585..379494)   379,448                                   C**A**C↔C**C**C     H335P
  379,483                                                                                        **G**CA↔**A**CA                      A347T                                                         
  (*lgc-*44) neurotransmitter-gated ion-channel ligand binding domain containing protein         nDi.2.2.scaf01696 (393..4458)        557                                       **C**TT↔**A**TT     L139I
  596                                                                                            **G**CA↔**A**CA                      A126T                                                         
  4443                                                                                           **G**CA↔**A**CA                      A6T                                                           
  (*lgc-*45)[b](#tbl4fnb){ref-type="table-fn"} cre-*lgc-*45 protein                              nDi.2.2.scaf02553 (1..1867)          1356                                      **G**AG↔**A**AG     E59K
  (*lgc-*55) cre-*lgc-*55 protein                                                                nDi.2.2.scaf00086 (64805..70168)     67,173                                    **C**CT↔**A**CT     P177T

Homolog genes with detrimental RNAi phenotype in *C. elegans*.

Absence of a significant BLAST hit (E-value below 10^−5^) in the predicted proteomes of *H. sapiens* and *C. lupus familiaris*.

SNP causes change in secondary structure of the protein as predicted by PSIPRED.

###### 

Summary of genes/subunits of voltage-gated and other channel types studied for polymorphism, SNPs identified and the SNP rate calculated among *Dirofilaria immitis* populations from different geographical locations.

  Channel types   No. of subunits studied   Base pairs covered   No. of SNPs identified   Polymorphic rate (%)         
  --------------- ------------------------- -------------------- ------------------------ ---------------------- ----- ------
  Calcium         26 (9)                    183,111              278                      46                     324   0.18
  Potassium       72 + 1\* (44)             313,602              245                      39                     284   0.09
  Chloride        13 (9)                    55,311               224                      41                     265   0.48
  DEG/ENaC        8 (7)                     52,637               91                       14                     105   0.20
  TRP             14 (7)                    82,860               280                      39                     319   0.38
  Others          8 (7)                     28,970               47                       11                     58    0.20

No. of unique genes are indicated in brackets. \*One auxiliary subunit of a potassium channel.

###### 

SNP analysis of potassium channel genes/subunits of *Dirofilaria immitis*.

  Putative gene name/description                                                                         Coverage in nDi.2.2 scaffold         SNP position in the scaffold   Nucleotide change   Amino acid polymorphism
  ------------------------------------------------------------------------------------------------------ ------------------------------------ ------------------------------ ------------------- -----------------------------------------
  (*irk-3*) inward rectifier potassium channel 2                                                         nDi.2.2.scaf0048335 (35621..36678)   35,701                         **C**GA↔**G**GA     R99G
  (*twk-48*) potassium channel subfamily k member 18-like                                                nDi.2.2.scaf00031 (282982..285733)   284,309                        A**T**C↔A**C**C     I171T
  (*twk-8*) t family of potassium channels protein                                                       nDi.2.2.scaf00297 (29943..41201)     31,960                         **A**TG↔**G**TG     M468V[c](#tbl6fnc){ref-type="table-fn"}
  *(twk-18)* cre-twk-18 protein                                                                          nDi.2.2.scaf01557 (1..1936)          1832                           **A**AA↔**T**AA     K103Stop
  1846                                                                                                   AT**G**↔AT**A**                      M107I                                              
  1869                                                                                                   C**G**A↔C**A**A                      R115Q                                              
  1875                                                                                                   T**C**T↔T**T**T                      S117F                                              
  *(twk-18)*[b](#tbl6fnb){ref-type="table-fn"} cre-twk-18 protein                                        nDi.2.2.scaf01557 (1976..6354)       1976                           **A**TG↔**G**TG     M1V
  1988                                                                                                   **C**AT↔**G**AT                      H5D                                                
  *(twk-47)*[a](#tbl6fna){ref-type="table-fn"}^,^[b](#tbl6fnb){ref-type="table-fn"} protein twk-47       nDi.2.2.scaf03721 (1..1197)          1172                           G**T**A↔GCA         V9A
  (*exp-2*) expulsion defective family member                                                            nDi.2.2.scaf00006 (218879..222098)   219,314                        G**T**A↔G**G**A     V24G
  (*kvs-4*) potassium voltage-gated channel subfamily b member 1                                         nDi.2.2.scaf00301 (583..5688)        4802                           A**C**A↔A**T**A     T208I
  *(shw-3)* cre-shw-3 protein                                                                            nDi.2.2.scaf05035 (1..436)           428                            A**G**C↔A**T**C     S3I
  (*shw-1*) voltage-gated potassium channel                                                              nDi.2.2.scaf07713 (1..653)           624                            **G**AC↔**A**AC     D80N
  (F59F3.6) k + channel tetramerisation domain containing protein                                        nDi.2.2.scaf00117 (106270..113892)   113,664                        AT**T**↔AT**G**     I194M[c](#tbl6fnc){ref-type="table-fn"}
  113,723                                                                                                G**C**T↔G**T**T                      A214V                                              
  (*unc-93*)[a](#tbl6fna){ref-type="table-fn"} potassium channel regulatory protein                      nDi.2.2.scaf00192 (61319..67673)     62,629                         C**G**A↔C**A**A     R131Q
  *(kcnl-2)*[a](#tbl6fna){ref-type="table-fn"} small conductance calcium-activated potassium isoform m   nDi.2.2.scaf01340 (1485..8980)       1522                           C**A**T↔C**G**T     H346R[c](#tbl6fnc){ref-type="table-fn"}

Homolog genes with detrimental RNAi phenotype in *C. elegans*.

Absence of a significant BLAST hit (E-value below 10^−5^) in the predicted proteomes of *H. sapiens* and *C. lupus familiaris*.

SNP causes change in secondary structure of the protein as predicted by PSIPRED.

###### 

SNP analysis of calcium channel genes/subunits of *Dirofilaria immitis*.

  Putative gene name/Description                                                                           Coverage in nDi2.2 scaffold          SNP position in the scaffold   Nucleotide change   Amino acid polymorphism
  -------------------------------------------------------------------------------------------------------- ------------------------------------ ------------------------------ ------------------- -----------------------------------------
  (*egl-19*) Ca                                                                                            nDi.2.2.scaf00156 (87..12852)        11,273                         **A**CC↔**C**CC     T1447P
  (*unc-2*) P/Q -- type calcium channel                                                                    nDi.2.2.scaf01292 (5521..9462)       7528                           **T**TG↔**G**TG     L163V
  (*cca-1*) calcium alpha subunit family member                                                            nDi.2.2.scaf02061 (1..2561)          748                            C**T**G↔C**C**G     L102P
  *(cca-1)* calcium alpha subunit family member (cca-1)                                                    nDi.2.2.scaf02732 (1..1740)          693                            **C**GA↔**G**GA     R130G
  (*nca-2*)[a](#tbl7fna){ref-type="table-fn"} four domain-type voltage-gated ion channel alpha-1 subunit   nDi.2.2.scaf00024 (97885..111975)    110,036                        **G**AA↔**A**AA     E1619K
  (*unc-36*) voltage-dependent calcium channel                                                             nDi.2.2.scaf00220 (32908..46275)     43,927                         G**T**G↔G**G**G     V147G[b](#tbl7fnb){ref-type="table-fn"}
  RyR[a](#tbl7fna){ref-type="table-fn"} ryanodine receptor 44f                                             nDi.2.2.scaf00024 (338721..388427)   345,969                        **C**AA↔**A**AA     Q4384K
  371,014                                                                                                  G**A**A↔G**G**A                      E1711G                                             
  371,999                                                                                                  **C**GA↔**G**GA                      R1587G                                             
  377,552                                                                                                  **A**CC↔**C**CC                      T1285P                                             
  385,665                                                                                                  C**T**T↔C**C**T                      L182P                                              
  (*unc-80*)[a](#tbl7fna){ref-type="table-fn"} uncoordinated family member                                 nDi.2.2.scaf00207 (43636..72270)     54,434                         A**C**G↔A**T**G     T1836M
  (*unc-79*)[a](#tbl7fna){ref-type="table-fn"} uncoordinated family member                                 nDi.2.2.scaf01338 (32..946)          923                            **G**CA↔**A**CA     A141T
  932                                                                                                      **T**TC↔**C**TC                      F144L                                              
  *(unc-79)*[a](#tbl7fna){ref-type="table-fn"} protein unc-79 homolog                                      nDi.2.2.scaf04898 (1..1130)          1125                           **CAA↔CAT**         Q2H

Homolog genes with detrimental RNAi phenotype in *C. elegans*.

SNP causes change in secondary structure of the protein as predicted by PSIPRED.

###### 

SNP analysis of chloride channel genes/subunits of *Dirofilaria immitis*.

  Putative gene name/Description                                  Coverage in nDi.2.2 scaffold         SNP position in the scaffold              Nucleotide change   Amino acid polymorphism
  --------------------------------------------------------------- ------------------------------------ ----------------------------------------- ------------------- -------------------------
  (*clh-1*) protein clh- isoform b                                nDi.2.2.scaf01639 (1..5958)          5052                                      G**C**T↔G**G**T     A300G
  5057                                                            **G**TT↔**T**TT                      V302F                                                         
  (*clh-3/clc-3*) voltage gated chloride channel family protein   nDi.2.2.scaf00125 (31151..45497)     31,476                                    A**G**T↔A**A**T     S1095N
  32,409                                                          **C**AA↔**A**AA                      Q915K                                                         
  (*clh-5/clc-5*) chloride channel protein 3                      nDi.2.2.scaf00353 (9838..16713)      14,624                                    **A**AT↔**C**AT     N325H
  (*clh-6/clc-6*) chloride channel protein 7 (ccp-7)              nDi.2.2.scaf00051 (224832..229977)   225,891                                   **G**TT↔**A**TT     V628I
  226,548                                                         G**T**G↔G**C**G                      V549A[a](#tbl8fna){ref-type="table-fn"}                       
  226,820                                                         **A**TT↔**G**TT                      I517V                                                         
  226,841                                                         **T**TT↔**G**TT                      F510V                                                         
  227,468                                                         **A**AT↔**G**AT                      N413D                                                         
  228,310                                                         G**C**G↔G**G**G                      A278G                                                         
  228,313                                                         G**C**T↔G**G**T                      A277G                                                         
  228,316                                                         G**T**G↔G**G**G                      V276G                                                         
  228,981                                                         **G**GT↔**A**GT                      G147S                                                         
  *(best-13)* bestrophin 1                                        nDi.2.2.scaf00401 (31248..33870)     32,314                                    G**C**T↔G**G**T     A136G
  33,830                                                          C**G**A↔C**A**A                      R384Q                                                         
  *(best-24)* bestrophin family protein                           nDi.2.2.scaf00816 (5183..11705)      5254                                      **G**AA↔**A**AA     E626K
  9709                                                            **C**AA↔**T**AA                      Q347Stop                                                      
  *(best-24)* bestrophin family protein                           nDi.2.2.scaf01764 (346..4516)        852                                       **T**TG↔**A**TG     L75M^c^

SNP causes change in secondary structure of the protein as predicted by PSIPRED.
